Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | PTGDR2 | Q9Y5Y4 | 9/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.56 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.54 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.54 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5389347 | 0.87 | TDP1 (0.77) | TDP1TSHRMAPTPTGDR2PTGDR | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL226803 | 0.85 | TDP1 (1.00) | TDP1TSHRMAPTPTGDR2PTGDR | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL31108925 | 0.85 | TDP1 (1.00) | TDP1TSHRMAPTPTGDR2PTGDR | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL11716042 | 0.85 | TDP1 (1.00) | TDP1TSHRMAPTPTGDR2PTGDR | |
| SCHEMBL9722688 | 0.85 | TDP1 (0.54) | TDP1TSHRMAPTMEN1KMT2A | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL27783 | 0.85 | TDP1 (1.00) | TDP1TSHRMAPTPTGDR2PTGDR | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL4586671 | 0.84 | TDP1 (0.96) | TDP1TSHRMAPTPTGDR2PTGDR | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL7618485 | 0.84 | TDP1 (0.96) | TDP1TSHRMAPTPTGDR2PTGDR | |
| SCHEMBL5395902 | 0.84 | MCL1 (0.68) | TDP1TSHRMAPTKMT2A | |
| 2,4-Dichlorophenoxyacetic Acid SCHEMBL17891942 | 0.84 | TDP1 (0.96) | TDP1TSHRMAPTPTGDR2PTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082500-A | Method for preparing single plant cell | 北京艾普希隆生物科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-4345097-A | Chlorination of phenols and phenoxyacetic acids with sulfuryl chloride | VERTAC CHEMICAL CORPORATION (US) | 1982-08-17 | — | — | US | claimed |
| CN-120082500-A | Method for preparing single plant cell | 北京艾普希隆生物科技有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119546182-A | Method for producing haploid/doubled haploid sunflower plants by microspore culture | 科沃施种子欧洲股份两合公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-110143932-B | Piperazinone derivatives, process for producing the same, inhibitor, and method for controlling root-parasitic weeds | 南开大学 | 2022-09-16 | — | — | CN | disclosed |
| CN-111493078-A | Use of piperazinone derivatives, an accelerator and a method for controlling root parasitic weeds | 南开大学 | 2020-08-07 | — | — | CN | disclosed |
| CN-110143932-A | Piperazinone derivs and preparation method thereof, inhibitor and the method for preventing and treating root parasitism weeds | 南开大学 | 2019-08-20 | — | — | CN | disclosed |
| WO-2019154284-A1 | PIPERAZINONE DERIVATIVE, PREPARATION METHOD THEREFOR, USE THEREOF, ACCELERATOR AND METHOD FOR CONTROLLING ROOT PARASITIC WEEDS | 南开大学 | 2019-08-15 | — | — | WO | disclosed |
| US-20150148311-A1 | NON-SYSTEMIC TGR5 AGONISTS | ARDELYX INC (US) | 2015-05-28 | — | — | US | disclosed |
| US-20150148311-A1 | NON-SYSTEMIC TGR5 AGONISTS | ARDELYX INC (US) | 2015-05-28 | — | — | US | disclosed |
| US-20150148311-A1 | NON-SYSTEMIC TGR5 AGONISTS | ARDELYX INC (US) | 2015-05-28 | — | — | US | disclosed |
| US-20080256666-A1 | METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2008-10-16 | — | — | US | disclosed |
| WO-2008121602-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-09 | — | — | WO | disclosed |
| US-20080189810-A1 | Compositions and Methods of Use of Response Regulators | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2008-08-07 | — | — | US | disclosed |
| WO-2006081060-A2 | COMPOSITIONS AND METHODS OF USE OF RESPONSE REGULATORS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2006-08-03 | — | — | WO | disclosed |
| US-20060168692-A1 | Compositions and methods of use of response regulators | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2006-07-27 | — | — | US | disclosed |
| EP-0122010-B1 | TIMED RELEASE DELIVERY MEANS FOR DELIVERY OF ACTIVE AGENT TO SPATIALLY SEPARATED TERRAIN LOCATIONS AND COMPOSITIONS COMPRISED THEREBY | METROPOLITAN MOSQUITO CONTROL DISTRICT (US) | 1988-11-02 | — | — | EP | disclosed |
| US-4345097-A | Chlorination of phenols and phenoxyacetic acids with sulfuryl chloride | VERTAC CHEMICAL CORPORATION (US) | 1982-08-17 | — | — | US | disclosed |
| US-4326882-A | Trichlorophenoxy alkanoic acid free of chlorinated dibenzo-p-dioxins | PPG INDUSTRIES, INC. (US) | 1982-04-27 | — | — | US | disclosed |
| US-4293707-A | Process for preparing trichlorophenoxy alkanoic acid and hydrolyzable derivatives thereof free of chlorinated dibenzo-p-dioxins | PPG INDUSTRIES, INC. (US) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148311-A1 | NON-SYSTEMIC TGR5 AGONISTS | GLP1R, GPR119, TRHR | TDP1 1293/4885TSHR 6/4885MAPT 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.